Literature DB >> 32894978

Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries.

Raffaella Calabretta1, Christoph Hoeller2, Verena Pichler1, Markus Mitterhauser1, Georgios Karanikas1, Alexander Haug1, Xiang Li1, Marcus Hacker1.   

Abstract

Entities:  

Keywords:  FDG; atherosclerosis; immune checkpoint inhibitor therapy; inflammation; positron emission tomography

Mesh：

Substances：

Year:  2020        PMID： 32894978     DOI： 10.1161/CIRCULATIONAHA.120.048708

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  17 in total

Review 1.  Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review.

Authors:  Jacqueline T Vuong; Ashley F Stein-Merlob; Arash Nayeri; Tamer Sallam; Tomas G Neilan; Eric H Yang
Journal:  J Am Coll Cardiol       Date:  2022-02-15       Impact factor: 24.094

2.  MUW researcher of the month.

Authors: 
Journal:  Wien Klin Wochenschr       Date:  2021-12       Impact factor: 1.704

3.  Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity.

Authors:  Abdulrazzak Zarifa; Juan Lopez-Mattei; Nicolas L Palaskas; Cezar Iliescu; Jean-Bernard Durand; Peter Y Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Effects of PD-1 blockade on ovarian follicles in a prepubertal female mouse.

Authors:  Pauline C Xu; Yi Luan; Seok-Yeong Yu; Jing Xu; Donald W Coulter; So-Youn Kim
Journal:  J Endocrinol       Date:  2021-11-24       Impact factor: 4.286

Review 5.  A Spotlight on Drug-Induced Vasculitis.

Authors:  Kinanah Yaseen; Alana Nevares; Hiromichi Tamaki
Journal:  Curr Rheumatol Rep       Date:  2022-09-21       Impact factor: 4.686

Review 6.  Immune-based therapies in cardiovascular and metabolic diseases: past, present and future.

Authors:  Andrew J Murphy; Mark A Febbraio
Journal:  Nat Rev Immunol       Date:  2021-07-20       Impact factor: 53.106

Review 7.  Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors.

Authors:  Alan H Baik; Katy K Tsai; David Y Oh; Mandar A Aras
Journal:  Clin Sci (Lond)       Date:  2021-03-12       Impact factor: 6.124

Review 8.  B Cells in Atherosclerosis: Mechanisms and Potential Clinical Applications.

Authors:  Tanyaporn Pattarabanjird; Cynthia Li; Coleen McNamara
Journal:  JACC Basic Transl Sci       Date:  2021-06-28

9.  Early Onset Acute Coronary Artery Occlusion After Pembrolizumab in Advanced Non-Small Cell Lung Cancer: A Case Report.

Authors:  Yuan Cheng; Ligong Nie; Wei Ma; Bo Zheng
Journal:  Cardiovasc Toxicol       Date:  2021-05-27       Impact factor: 3.231

Review 10.  Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem.

Authors:  Kikkie Poels; Suzanne I M Neppelenbroek; Marie José Kersten; M Louisa Antoni; Esther Lutgens; Tom T P Seijkens
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.